3-benzyl-5-chloro-2-methoxypyrido[2,3-g]quinoxaline

ID: ALA3736323

PubChem CID: 127035324

Max Phase: Preclinical

Molecular Formula: C19H14ClN3O

Molecular Weight: 335.79

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1nc2cc3cccnc3c(Cl)c2nc1Cc1ccccc1

Standard InChI:  InChI=1S/C19H14ClN3O/c1-24-19-15(10-12-6-3-2-4-7-12)22-18-14(23-19)11-13-8-5-9-21-17(13)16(18)20/h2-9,11H,10H2,1H3

Standard InChI Key:  VPCYYJBRCLBDAB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   -2.5978    1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8968    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8968   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5978   -1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2989   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2806   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2806    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2989    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978    1.5002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968    0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8968   -0.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978   -1.5002    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1950    1.5032    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1933    2.7032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0037   -2.7002    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.1950   -1.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1928   -3.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4893   -3.7586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4841   -5.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1825   -6.0041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8860   -5.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8912   -3.7496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  7 14  2  0
  8 11  2  0
 15 16  1  0
  2 15  1  0
  6 17  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
  3 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3736323

    ---

Associated Targets(Human)

MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bovine viral diarrhea virus 1 (1277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Yellow fever virus (1530 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Coxsackievirus B5 (476 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human poliovirus 1 strain Sabin (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Respiratory syncytial virus (3434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 335.79Molecular Weight (Monoisotopic): 335.0825AlogP: 4.43#Rotatable Bonds: 3
Polar Surface Area: 47.90Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.10CX LogP: 4.46CX LogD: 4.46
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.52Np Likeness Score: -0.81

References

1. Briguglio I, Loddo R, Laurini E, Fermeglia M, Piras S, Corona P, Giunchedi P, Gavini E, Sanna G, Giliberti G, Ibba C, Farci P, La Colla P, Pricl S, Carta A..  (2015)  Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives.,  105  [PMID:26479028] [10.1016/j.ejmech.2015.10.002]

Source